(Q36238011)

English

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Michael J Barry

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Michael A Delorenzo

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Elizabeth S Walker-Corkery

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

F Lee Lucas

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David C Wennberg

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

28 July 2006

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

BJU International

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

98

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

973-978

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Critical evaluation of hormonal therapy for carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Hormonal therapy in the management of prostate cancer: from Huggins to the present

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

The case for prostate cancer screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

1 October 2017

National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

29 June 2018

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

29 June 2018

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Medical versus surgical androgen suppression therapy for prostate cancer: a 10-year longitudinal cost study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

22 September 2018

The lifetime risk of developing prostate cancer in white and black men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121185

22 September 2018

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06416.X

21 January 2018

Should routine screening for prostate-specific antigen be recommended?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16879443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16879443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prostate cancer conundrum

1 reference

https://pubmed.ncbi.nlm.nih.gov/16879443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for prostate cancer: enthusiasm

1 reference

https://pubmed.ncbi.nlm.nih.gov/16879443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-410X.2006.06416.X

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36238011&oldid=1621943546"